Patient Access Advocacy for BTK Inhibitors

Video content above is prompted by the following:

• How do changes in patient out-of-pocket costs under the IRA influence treatment and sequencing decisions?
• What strategies can healthcare providers use to advocate for patient access to BTK inhibitors?